IFP Advisors, Inc - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2023$595
+19733.3%
100
-75.0%
0.00%
Q4 2022$3
-99.8%
400
+33.3%
0.00%
Q3 2022$2,0000.0%3000.0%0.00%
Q2 2022$2,000
-33.3%
300
-25.0%
0.00%
Q1 2022$3,000
+200.0%
400
+300.0%
0.00%
Q4 2021$1,0000.0%1000.0%0.00%
Q3 2021$1,0001000.00%
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$0
-100.0%
0
-100.0%
0.00%
Q3 2020$4,000
-94.2%
2,373
-72.9%
0.00%
-100.0%
Q2 2020$69,000
+53.3%
8,769
+9.8%
0.01%0.0%
Q1 2020$45,000
+2.3%
7,9890.0%0.01%
+66.7%
Q4 2019$44,000
-8.3%
7,989
-15.8%
0.00%0.0%
Q3 2019$48,000
+1100.0%
9,489
+1536.0%
0.00%
+200.0%
Q1 2019$4,000
-100.0%
580
-100.0%
0.00%
-99.8%
Q4 2018$9,458,000
-16.8%
1,608,569
+6.8%
0.58%
+24.4%
Q3 2018$11,372,000
+50.0%
1,506,246
+0.4%
0.46%
+45.1%
Q2 2018$7,579,000
+6.7%
1,500,805
+50.0%
0.32%
-0.9%
Q1 2018$7,106,0000.0%1,000,8050.0%0.32%0.0%
Q4 2017$7,106,000
-0.7%
1,000,805
-0.0%
0.32%
+13.4%
Q3 2017$7,157,000
+13.5%
1,001,0250.0%0.28%
+6.4%
Q2 2017$6,306,000
-35.1%
1,001,025
-15.0%
0.27%
-37.0%
Q1 2017$9,717,000
+118.9%
1,177,925
+124.2%
0.42%
+98.1%
Q4 2016$4,440,000
+118.0%
525,500
+75.2%
0.21%
+101.9%
Q3 2016$2,037,000
+50825.0%
300,000
+51624.1%
0.11%
+10500.0%
Q1 2016$4,0005800.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders